Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method
Key Elements for Standardized Reporting in Prostate Cancer Management: An Expert Delphi Consensus Study
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 21 Years and older
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Time periods mentioned: 2 weeks
- Procedures mentioned: Questionnaires
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "The goal of this survey study is to have a panel of specialty-specific experts create a consensus agreement on a minimum set of key data elements for use in standardized reports."
- "OUTLINE: Participants complete 3-4 rounds of questionnaires over 20-30 minutes each over 2 weeks."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This online survey study asks prostate cancer experts to agree on key facts to include in patient health records. The goal is to make cancer care reports more consistent, from diagnosis through treatment and follow-up. It is for board-certified experts who actively care for people with prostate cancer.
This study formulates consensus agreement on clinical key elements related to prostate cancer care that are critical for standardization and global reported using a robust Delphi technique, completely remote and electronic. The goal of this survey study is to have a panel of specialty-specific experts create a consensus agreement on a minimum set of key data elements for use in standardized reports. These recommendations would be used to develop standardized methods to report key data in electronic health records to better manage cancer patients at time of diagnosis, treatment, follow up, and into survivorship.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Age 21 or older.
- Board-certified in radiation oncology (radiation cancer treatment), radiation physics (the science of radiation treatment), urology (urinary and male reproductive care), or medical oncology (cancer drug treatment).
- Have an active practice that includes people with prostate cancer.
- Speak English.
Who can't join
- Medical providers who lack board certification in the listed fields or do not treat prostate cancer.
- People in prison.
- Children and adults who cannot consent to take part.
- The listing says there are no exclusions based on sex, age, race, ethnic background, or pregnancy. However, it also requires participants to be at least 21.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Age 21 and above * Board certification in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology * Maintenance of an active practice that includes prostate cancer patients * English speaking Exclusion Criteria: * Medical providers that are not board certified in the professions and/or those who do not treat prostate cancer * Prisoners, children, and adults unable to consent to participation will also be excluded * No exclusions were made based on sex, age, racial/ethnic background, or pregnancy status
Study sites (1)
TX
- M D Anderson Cancer Center · Houston, TX 77030Amy C. Moreno · Study contact · 832-728-6162 · akmoreno@mdanderson.orgAmy C. Moreno · Principal investigatorMore trials in Houston